We assign a technical rating of 3 out of 10 to CDNA. Although CDNA is scoring some points because its good overall performance in the market in the past year, recent evolutions are not that positive. Both the medium and short term picture give negative signs.
Both the long and short term trends are negative. It is better to avoid buying stocks with negative trends.
CDNA is currently trading in the lower part of its 52 week range, which is not a good signal. Agreed, the S&P500 Index is also not doing fantastic, but it still sitting in the middle of its 52 week range.
In the last month CDNA has a been trading in the 14.86 - 20.13 range, which is quite wide. It is currently trading near the lows of this range.
Prices have been falling strongly lately, it is better to avoid new long positions here.
Volume is considerably higher in the last couple of days. In combination with the strong move down this is a bad signal.
CDNA is part of the Biotechnology industry. There are 567 other stocks in this industry. CDNA outperforms 84% of them.
Looking at the yearly performance, CDNA did better than 82% of all other stocks. We also observe that the gains produced by CDNA over the past year are nicely spread over this period. However, this overall performance is mostly based on the strong move around 10 months ago.